Those interested in #Socialmedia in health care, check our this project Previvorship www.previvorship.org) report on Social Media for Carriers of Hereditary Syndromes lnkd.in/eds-kMDm #gyncsm #lynchsyndrome #BRCA #bcsm

Thanks Marie Ennis-O'Connor and Linda Caroll for the writing prompt that developed into this blog post.
Why I write...
womenofteal.blogspot.com/2026/03/why-... #gyncsm

Mark your calendars! The next chat takes place on April 7th during GLOBAL #AYACSM week!!!!

#AYACancerAwareness #BTSM #BCSM #LCSM #GYNCSM #ChildhoodCancer

Self #acupressure decreased cancer-related fatigue and improved quality of life compared with usual care for women with #ovariancancer. Published in @jamanetworkopen.com.

https://bit.ly/4rnqbBn

#gyncsm #cancerfatigue

GLP-1 Therapy Plus Progestin May Reduce Endometrial Cancer Risk in Some Patients In this cohort study, researchers aimed to examine endometrial cancer and hysterectomy patterns in patients who had endometrial hyperplasia or benign uterine pathology and were receiving progestins with or without GLP-1RAs or metformin.

For patients with endometrial hyperplasia or benign uterine pathology, receiving progestin in combination with #GLP1RA therapy is associated with a reduced risk of #endometrialCancer. Published in @jamanetworkopen.com.

https://bit.ly/4bOhdrR

#gyncsm #GLP1

Now open at UT Southwestern Simmons Cancer Center.

#gyncsm #clinicaltrial

A women in a fabulous suit giving a podium talk on brachytherapy for gyn cancer

Dr Onyinye Balogun at #ACRO2026 on best practices in #gyncsm #brachytherapy
including proper pain management during and after procedures. "we don't want our field trending on Tik tok for the wrong reason"

Pan-Canadian research team dedicated to improving the lives of children with cancer and their families In 2022, the Canadian Institutes of Health Research (CIHR) launched a $23 million team-grant opportunity to support the establishment of a national pediatric cancer consortium that would change the wa...

Check out our new study re: #ChildhoodCancer on this #WorldCancerDay👇

www.mcgill.ca/nursing/arti...

#BCSM #BTSM #AYACSM #GYNCSM @healthsciences.mcgill.ca

Q2: What challenges have you faced recently in using #SocialMedia for #AYACancer/ #Cancer advocacy?

#AYACSM #LCSM #BTSM #BCSM #GYNCSM

[#AYACSM] Our next public conversation is taking place tomorrow (Tues, Feb. 3rd) night at 8 PM EST. Join us as we discuss living in a digital world and how that impacts our adolescent and young adults (AYA) cancer advocacy initiatives!

#Oncology #Cancer #AYACancer #BTSM #BCSM #GYNCSM #LCSM #HPM

SCORES: Suvemcitug Shows Promise in Platinum-Resistant Ovarian Cancer Adding the VEGF antibody suvemcitug to chemotherapy significantly improved survival for patients with ovarian cancer who progressed followed

Adding the VEGF antibody suvemcitug to chemotherapy significantly improved survival for patients with #ovariancancer who progressed followed platinum-based chemotherapy. Published in @natcancer.nature.com.

https://bit.ly/3NRPHj3

#gyncsm

Updates to post-treatment surveillance after curative intent treatment for patients with gynecologic cancers: A Society of Gynecologic Oncology clinical practice statement - Gynecologic Oncology www.gynecologiconcology-online.net/article/S009... #gyncsm

Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications - Archives of Gynecology and Obstetrics A relevant proportion of malignancies predominantly or exclusively affecting women, including breast and gynecologic cancers, is attributable to hereditary tumor syndromes, profoundly impacting cancer...

This review provides a comprehensive overview of #hereditarycancer predisposing to breast and gynecologic malignancies, with a focus on genetic basis, associated cancer risks, and implications for clinical management.

#bcsm #gyncsm #genetics #womenshealth #cancerresearch #medsky

I said goodbye to my best friend, Amber, yesterday. She was my best survivorship therapy. #gyncsm womenofteal.blogspot.com/2026/01/beyo...

In Ovarian Cancer, Interval Debulking Surgery Leads to Fewer Complications, Does Not Affect Survival In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who received interval debulking surgery compared to primary debulking surgery.

In patients with advanced #ovariancancer, undergoing interval debulking surgery results in similar survival outcomes as primary debulking surgery.

https://bit.ly/4qFQ12r

#gyncsm

In Ovarian Cancer, Interval Debulking Surgery Leads to Fewer Complications, Does Not Affect Survival In this systematic review and meta-analysis, researchers examined outcomes among advanced ovarian cancer patients who received interval debulking surgery compared to primary debulking surgery.

In patients with advanced #ovariancancer, undergoing interval debulking surgery results in similar survival outcomes as primary debulking surgery.

https://bit.ly/4qFQ12r

#gyncsm

Research Study for the Genetics of Breast Cancer - Open now led by Dr. Tara Matise ( @facingourrisk.bsky.social
and Rutgers University) Rutgers Genetics Coordinating Center
bcstudy.org/FORCE
Open in the US to 18yrs +, having had cancer or not, with Internet access. #gyncsm #bcsm #lcsm

Tamoxifen Use May Increase Endometrial Cancer Risk in  Premenopausal Patients with Breast Cancer - Oncology Nurse Advisor In this retrospective cohort study of a large population in Belgium, researchers aimed to examine endometrial cancer risk in patients with breast cancer who received tamoxifen.

In premenopausal women with non-metastatic #breastcancer, use of tamoxifen may nearly double the risk of #endometrialcancer. Presented in a poster at @sabcs.bsky.social #SABCS25, from @cancertherapyadv.bsky.social.

https://bit.ly/4aPZUpV

#bcsm #gyncsm

Coming up this Tuesday!! Our first #AYACSM chat of 2026!!

ALL are welcome from our other #OncSky communities: #BTSM #BCSM #LCSM #GYNCSM #ChildhoodCancer

#TYACancer #AYACancer

The Essential but Often Complex Role of Numbers and Measurements in Oncology, Continued | OncLive Maurie Markman, MD, discusses the essential but often complex role associated with the interpretation of numbers and measurements in oncology.

The Essential but Often Complex Role of Numbers and Measurements in Oncology, Continued @cityofhopecologne.bsky.social
#gyncsm #oncology
www.onclive.com/view/the-ess...

Reminder to let me know if you want to be part of the #AYACSM calendar reminders! Next chat is this Tuesday!

Welcoming all from the #BTSM, #LCSM, #BCSM, #OncSky, #GYNCSM etc. communities!!

Adding Atezolizumab to Standard Therapy Fails to Improve Survival in Recurrent Ovarian Cancer - Oncology Nurse Advisor Investigators evaluated atezolizumab combined with bevacizumab and non–platinum-based chemotherapy for patients with recurrent ovarian cancer.

Atezolizumab in combination with bevacizumab and non-platinum-based chemotherapy did not significantly improve survival in patients with recurrent #ovarianCancer. Published in @ascopost.bsky.social Journal of Clinical Oncology and @cancertherapyadv.bsky.social.

https://bit.ly/49sianV

#gyncsm

Fuzuloparib Extends PFS as Maintenance Therapy for Advanced Ovarian Cancer FZOCUS-1 assessed the safety and efficacy of fuzuloparib alone and in combination with apatinib for patients with newly diagnosed or advanced ovarian cancer.

Fuzuloparib monotherapy extended PFS by more than 15 months for patients with #ovariancancer compared with placebo. Published in @americancancersoc.bsky.social CA Cancer Journal.

https://bit.ly/4sbJ22Q

#gyncsm

Few US Women Receive Guideline Concordant Cervical Cancer Screening Investigators examined cervical cancer screening guideline adherence among a nationally representative commercially insured cohort in the US to identify factors and modalities associated with nonadherence and test for interactions between race, ethnicit...

Most US women are receiving improper screening for #cervicalcancer. Published in @jamanetworkopen.com

https://bit.ly/48R1EO9

#gyncsm

One Dose of HPV Vaccine Is Just as Good as Two Investigators sought to determine whether a single dose of HPV vaccine would provide similar protection as two doses.

A single dose of the bivalent or nonavalent #HPV vaccine is sufficient to provide protection against HPV16 or HPV18 infection and is noninferior to 2 doses. Published in @nejm.org

https://bit.ly/4qml8zY

#intonc #gyncsm

The Angelina Jolie Effect: A Lasting Global Impact on Cancer Prevention - OncoDaily “Angelina Jolie effect”: a measurable, sustained increase in genetic testing, cancer screening, and awareness worldwide.

The Angelina Jolie Effect: A Lasting Global Impact on #BRCA #HereditaryCancer Prevention. @oncodaily.bsky.social

#bcsm #gyncsm #genetics #womenshealth #medsky #patientexperience

Adding Atezolizumab to Standard Therapy Fails to Improve Survival in Recurrent Ovarian Cancer Investigators evaluated atezolizumab combined with bevacizumab and non–platinum-based chemotherapy for patients with recurrent ovarian cancer.

Atezolizumab in combination with bevacizumab and non-platinum-based chemotherapy did not significantly improve survival in patients with recurrent #ovariancancer. Published in @ascopost.bsky.social Journal of Clinical Oncology.

https://bit.ly/4s34FT5

#gyncsm

#GynCsm | Preliminary data of LEPRE study - open-label, phase 3 trial across 35 European oncology centers - suggest that #letrozole maintains safety profile expected for a hormonal agent in low-grade serous #carcinoma of the ovary #LGSCO

🔗 journals.sagepub.com/share/KHFI8T...

#CanSky #OncSky

Women in Low-Income Countries Face Treatment Delays in Early-Stage Cancer - Oncology Nurse Advisor Researchers assessed variations in patterns of care and time to initial treatment for women diagnosed with breast, cervical, or ovarian cancer in various countries.

These treatment delays can lead to more advanced stage #cancers and “suboptimal treatment,” the researchers wrote in their report. Published in @thelancet.com and @cancertherapyadv.bsky.social.

https://bit.ly/3Mdl5YN

#bcsm #gyncsm

Beyond BRCA: Decoding High-Grade Serous Ovarian Cancer In the ongoing quest to understand the complexities of ovarian cancer, a groundbreaking study co-authored by Pokorna, Orlickova, Machackova, and their team sheds light on the genomic intricacies and

Genomic complexity and evolution of high-grade serous #ovariancancer treated with platinum-based chemotherapy: advancing precision oncology beyond BRCA.

#gyncsm #womenshealth #cancerresearch #medsky